Rare emergence of delamanid resistance in multidrug-/rifampicin-resistant tuberculosis patients receiving delamanid-containing regimens: a prospective multicentric study in China

Abstract Background Delamanid (DLM) is a promising drug recommended for treatment of multidrug-/rifampicin-resistant tuberculosis (MDR/RR-TB). However, there are very little data about the emergence of drug resistance in patients with the use of DLM-containing regimens. The study aimed to monitor th...

Descripción completa

Detalles Bibliográficos

Autores principales:	Wei Shu, Qingshan Cai, Yuping Huang, Yuanhong Xu, Yuanyuan Shang, Ruixia Liang, Liang Yan, Lin Wang, Long Jin, Yi Pei, Zhongfeng Huang, Shanshan Li, Yufeng Wang, Mengqiu Gao, Liang Li, Yu Pang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2026-07-01
Colección:	Annals of Clinical Microbiology and Antimicrobials
Materias:	Tuberculosis Delamanid resistance Multidrug-/Rifampicin-resistant
Acceso en línea:	https://doi.org/10.1186/s12941-025-00820-9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!